Explore the latest in ischemic heart disease, including advances in PCI and in the diagnosis and management of acute coronary syndromes.
Ischemic heart diseaseCoronary artery disease (CAD) is still the leading cause of death in industrialized nations. Even though revascularization strategies such as percutaneous coronary intervention (PCI) and coronary artery bypass graft surgery (CABG) as well as drug therapy have significantly reduced ...
The Surgical Treatment for Ischemic Heart Failure (STICH) trial randomized 1212 patients withischemic cardiomyopathywith anejection fractionof less than 35% to eitherCABGor medical therapy. This was a complex patient population and included a high prevalence of patients with diabetes, previous MI, ...
Ischemic heart disease (IHD) is the leading cause of death and chronic disability in the world. IHD affects both the systolic and diastolic function of the heart which progressively leads to heart failure; a structural and functional impairment of filling or ejection of blood from the heart. In...
MATERIAL AND METHODS: We followed 619 patients with ischemic heart disease (IHD) and multivessel involvement of coronary arteries: 317 patients subjected to coronary artery bypass grafting (CABG, group 1) and 302 patients subjected to multivessel percutaneous coronary intervention (PCI, group 2) with...
Ischemic heart disease (IHD) is the leading cause of death in the European Union and the Western world1,2. Prevalence is rising constantly due to an aging population. Ischemia results in replacement of functional cardiomyocytes with non-contractile fibrotic scar tissue. Decreased cardiac output due...
Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: Scandinavian Simvastatin Survival Study (4S) Lancet, 344 T. Investigators(1997) Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel dise...
First, in the ISCHEMIA trial, 76% of patients had multivessel disease, 25% of those randomized to the invasive strategy underwent CABG, and only 20% had revascularization guided by FFR. In contrast, patients underwent PCI exclusively in the present study and all patients had revascularization ...
Background: Ischemic heart disease is a significant complication of atherosclerosis. Myocardial infarction after the development of coronary artery disease can lead to a number of serious complications, including ischemic mitral regurgitation (IMR). Currently there is no consensus regarding the preferred th...
Subgroup analysis was performed within the ICM cohort comparing off-pump CABG (OPCAB) versus on-pump CABG (ONCAB). Results: ICM patients had a higher incidence of myocardial infarction (MI), diabetes, chronic kidney disease (CKD), and preoperative intra-aortic balloon pump (IABP) use. The ...